nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—multiple sclerosis	0.849	1	CbGaD
Succinylcholine—BCHE—Triamcinolone—multiple sclerosis	0.0354	1	CbGbCtD
Succinylcholine—Myasthenia gravis—Azathioprine—multiple sclerosis	0.00689	0.0617	CcSEcCtD
Succinylcholine—Myasthenia gravis—Betamethasone—multiple sclerosis	0.00381	0.0341	CcSEcCtD
Succinylcholine—Myasthenia gravis—Dexamethasone—multiple sclerosis	0.00381	0.0341	CcSEcCtD
Succinylcholine—Decamethonium—BCHE—multiple sclerosis	0.00371	1	CrCbGaD
Succinylcholine—Intraocular pressure increased—Prednisolone—multiple sclerosis	0.0028	0.0251	CcSEcCtD
Succinylcholine—Cardiac arrest—Fingolimod—multiple sclerosis	0.00278	0.0249	CcSEcCtD
Succinylcholine—Intraocular pressure increased—Triamcinolone—multiple sclerosis	0.00257	0.023	CcSEcCtD
Succinylcholine—Intraocular pressure increased—Methylprednisolone—multiple sclerosis	0.00257	0.023	CcSEcCtD
Succinylcholine—Intraocular pressure increased—Betamethasone—multiple sclerosis	0.00233	0.0209	CcSEcCtD
Succinylcholine—Intraocular pressure increased—Dexamethasone—multiple sclerosis	0.00233	0.0209	CcSEcCtD
Succinylcholine—Bradycardia—Fingolimod—multiple sclerosis	0.00206	0.0184	CcSEcCtD
Succinylcholine—Intraocular pressure increased—Prednisone—multiple sclerosis	0.00203	0.0182	CcSEcCtD
Succinylcholine—Renal failure acute—Cladribine—multiple sclerosis	0.00179	0.0161	CcSEcCtD
Succinylcholine—Hypertension—Fingolimod—multiple sclerosis	0.00152	0.0136	CcSEcCtD
Succinylcholine—Hyperkalaemia—Mitoxantrone—multiple sclerosis	0.00147	0.0132	CcSEcCtD
Succinylcholine—Hypotension—Fingolimod—multiple sclerosis	0.00134	0.012	CcSEcCtD
Succinylcholine—Renal failure—Cladribine—multiple sclerosis	0.00125	0.0112	CcSEcCtD
Succinylcholine—Renal failure acute—Mitoxantrone—multiple sclerosis	0.00118	0.0106	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.00113	0.0101	CcSEcCtD
Succinylcholine—Pulmonary oedema—Prednisolone—multiple sclerosis	0.0011	0.00981	CcSEcCtD
Succinylcholine—Arrhythmia—Cladribine—multiple sclerosis	0.00102	0.00917	CcSEcCtD
Succinylcholine—Pulmonary oedema—Triamcinolone—multiple sclerosis	0.00101	0.00902	CcSEcCtD
Succinylcholine—Pulmonary oedema—Methylprednisolone—multiple sclerosis	0.00101	0.009	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000923	0.00827	CcSEcCtD
Succinylcholine—Pulmonary oedema—Dexamethasone—multiple sclerosis	0.000914	0.00818	CcSEcCtD
Succinylcholine—Pulmonary oedema—Betamethasone—multiple sclerosis	0.000914	0.00818	CcSEcCtD
Succinylcholine—Apnoea—Methotrexate—multiple sclerosis	0.000882	0.00789	CcSEcCtD
Succinylcholine—Cardiac arrest—Prednisolone—multiple sclerosis	0.00085	0.00761	CcSEcCtD
Succinylcholine—Myalgia—Cladribine—multiple sclerosis	0.000849	0.00761	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000849	0.0076	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000847	0.00758	CcSEcCtD
Succinylcholine—Arrhythmia—Azathioprine—multiple sclerosis	0.000832	0.00745	CcSEcCtD
Succinylcholine—Renal failure—Mitoxantrone—multiple sclerosis	0.000825	0.00739	CcSEcCtD
Succinylcholine—Pulmonary oedema—Prednisone—multiple sclerosis	0.000796	0.00713	CcSEcCtD
Succinylcholine—Tachycardia—Cladribine—multiple sclerosis	0.000795	0.00712	CcSEcCtD
Succinylcholine—Cardiac arrest—Triamcinolone—multiple sclerosis	0.000781	0.007	CcSEcCtD
Succinylcholine—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.000779	0.00698	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00077	0.0069	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00077	0.0069	CcSEcCtD
Succinylcholine—Bradycardia—Mitoxantrone—multiple sclerosis	0.000767	0.00687	CcSEcCtD
Succinylcholine—Respiratory failure—Methotrexate—multiple sclerosis	0.000761	0.00682	CcSEcCtD
Succinylcholine—Hypotension—Cladribine—multiple sclerosis	0.000761	0.00681	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000742	0.00664	CcSEcCtD
Succinylcholine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.000709	0.00635	CcSEcCtD
Succinylcholine—Cardiac arrest—Betamethasone—multiple sclerosis	0.000709	0.00635	CcSEcCtD
Succinylcholine—Bronchospasm—Methylprednisolone—multiple sclerosis	0.000697	0.00624	CcSEcCtD
Succinylcholine—Myalgia—Azathioprine—multiple sclerosis	0.000691	0.00618	CcSEcCtD
Succinylcholine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000673	0.00603	CcSEcCtD
Succinylcholine—Pulmonary oedema—Methotrexate—multiple sclerosis	0.000665	0.00596	CcSEcCtD
Succinylcholine—Urticaria—Cladribine—multiple sclerosis	0.000647	0.00579	CcSEcCtD
Succinylcholine—Body temperature increased—Cladribine—multiple sclerosis	0.000644	0.00576	CcSEcCtD
Succinylcholine—Bradycardia—Prednisolone—multiple sclerosis	0.000629	0.00563	CcSEcCtD
Succinylcholine—Hypotension—Azathioprine—multiple sclerosis	0.000619	0.00554	CcSEcCtD
Succinylcholine—Cardiac arrest—Prednisone—multiple sclerosis	0.000617	0.00553	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000603	0.0054	CcSEcCtD
Succinylcholine—Hypersensitivity—Cladribine—multiple sclerosis	0.0006	0.00537	CcSEcCtD
Succinylcholine—Renal failure acute—Methotrexate—multiple sclerosis	0.000588	0.00526	CcSEcCtD
Succinylcholine—Bradycardia—Triamcinolone—multiple sclerosis	0.000579	0.00518	CcSEcCtD
Succinylcholine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000577	0.00517	CcSEcCtD
Succinylcholine—Hypertension—Mitoxantrone—multiple sclerosis	0.000566	0.00507	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000561	0.00502	CcSEcCtD
Succinylcholine—Myalgia—Mitoxantrone—multiple sclerosis	0.000558	0.005	CcSEcCtD
Succinylcholine—Arrhythmia—Prednisolone—multiple sclerosis	0.000552	0.00494	CcSEcCtD
Succinylcholine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000535	0.00479	CcSEcCtD
Succinylcholine—Shock—Mitoxantrone—multiple sclerosis	0.000527	0.00471	CcSEcCtD
Succinylcholine—Bradycardia—Betamethasone—multiple sclerosis	0.000525	0.0047	CcSEcCtD
Succinylcholine—Bradycardia—Dexamethasone—multiple sclerosis	0.000525	0.0047	CcSEcCtD
Succinylcholine—Body temperature increased—Azathioprine—multiple sclerosis	0.000523	0.00469	CcSEcCtD
Succinylcholine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000522	0.00468	CcSEcCtD
Succinylcholine—Rash—Cladribine—multiple sclerosis	0.000513	0.0046	CcSEcCtD
Succinylcholine—Dermatitis—Cladribine—multiple sclerosis	0.000513	0.00459	CcSEcCtD
Succinylcholine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000508	0.00455	CcSEcCtD
Succinylcholine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000507	0.00454	CcSEcCtD
Succinylcholine—Hypotension—Mitoxantrone—multiple sclerosis	0.0005	0.00448	CcSEcCtD
Succinylcholine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000488	0.00437	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000488	0.00437	CcSEcCtD
Succinylcholine—Hypertension—Prednisolone—multiple sclerosis	0.000465	0.00416	CcSEcCtD
Succinylcholine—Arrhythmia—Betamethasone—multiple sclerosis	0.000461	0.00413	CcSEcCtD
Succinylcholine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000461	0.00413	CcSEcCtD
Succinylcholine—Bradycardia—Prednisone—multiple sclerosis	0.000457	0.00409	CcSEcCtD
Succinylcholine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000439	0.00393	CcSEcCtD
Succinylcholine—Shock—Prednisolone—multiple sclerosis	0.000432	0.00387	CcSEcCtD
Succinylcholine—Tachycardia—Prednisolone—multiple sclerosis	0.000429	0.00384	CcSEcCtD
Succinylcholine—Hypertension—Triamcinolone—multiple sclerosis	0.000427	0.00382	CcSEcCtD
Succinylcholine—Hypertension—Methylprednisolone—multiple sclerosis	0.000426	0.00382	CcSEcCtD
Succinylcholine—Urticaria—Mitoxantrone—multiple sclerosis	0.000425	0.00381	CcSEcCtD
Succinylcholine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000423	0.00379	CcSEcCtD
Succinylcholine—Myalgia—Triamcinolone—multiple sclerosis	0.000421	0.00377	CcSEcCtD
Succinylcholine—Myalgia—Methylprednisolone—multiple sclerosis	0.00042	0.00376	CcSEcCtD
Succinylcholine—Rash—Azathioprine—multiple sclerosis	0.000417	0.00374	CcSEcCtD
Succinylcholine—Dermatitis—Azathioprine—multiple sclerosis	0.000417	0.00373	CcSEcCtD
Succinylcholine—Flushing—Prednisone—multiple sclerosis	0.000417	0.00373	CcSEcCtD
Succinylcholine—Renal failure—Methotrexate—multiple sclerosis	0.000411	0.00368	CcSEcCtD
Succinylcholine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000404	0.00362	CcSEcCtD
Succinylcholine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000403	0.00361	CcSEcCtD
Succinylcholine—Arrhythmia—Prednisone—multiple sclerosis	0.000401	0.00359	CcSEcCtD
Succinylcholine—Shock—Triamcinolone—multiple sclerosis	0.000397	0.00356	CcSEcCtD
Succinylcholine—Shock—Methylprednisolone—multiple sclerosis	0.000396	0.00355	CcSEcCtD
Succinylcholine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000394	0.00353	CcSEcCtD
Succinylcholine—Tachycardia—Triamcinolone—multiple sclerosis	0.000394	0.00353	CcSEcCtD
Succinylcholine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000393	0.00352	CcSEcCtD
Succinylcholine—Hypertension—Dexamethasone—multiple sclerosis	0.000388	0.00347	CcSEcCtD
Succinylcholine—Hypertension—Betamethasone—multiple sclerosis	0.000388	0.00347	CcSEcCtD
Succinylcholine—Myalgia—Betamethasone—multiple sclerosis	0.000382	0.00342	CcSEcCtD
Succinylcholine—Myalgia—Dexamethasone—multiple sclerosis	0.000382	0.00342	CcSEcCtD
Succinylcholine—Hypotension—Methylprednisolone—multiple sclerosis	0.000376	0.00337	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000368	0.00329	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000367	0.00329	CcSEcCtD
Succinylcholine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000366	0.00328	CcSEcCtD
Succinylcholine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000366	0.00328	CcSEcCtD
Succinylcholine—Shock—Betamethasone—multiple sclerosis	0.00036	0.00323	CcSEcCtD
Succinylcholine—Shock—Dexamethasone—multiple sclerosis	0.00036	0.00323	CcSEcCtD
Succinylcholine—Tachycardia—Betamethasone—multiple sclerosis	0.000358	0.0032	CcSEcCtD
Succinylcholine—Tachycardia—Dexamethasone—multiple sclerosis	0.000358	0.0032	CcSEcCtD
Succinylcholine—Urticaria—Prednisolone—multiple sclerosis	0.000349	0.00312	CcSEcCtD
Succinylcholine—Hypotension—Betamethasone—multiple sclerosis	0.000342	0.00307	CcSEcCtD
Succinylcholine—Hypotension—Dexamethasone—multiple sclerosis	0.000342	0.00307	CcSEcCtD
Succinylcholine—Hypertension—Prednisone—multiple sclerosis	0.000338	0.00302	CcSEcCtD
Succinylcholine—Rash—Mitoxantrone—multiple sclerosis	0.000337	0.00302	CcSEcCtD
Succinylcholine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000337	0.00302	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000334	0.00299	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000334	0.00299	CcSEcCtD
Succinylcholine—Myalgia—Prednisone—multiple sclerosis	0.000333	0.00298	CcSEcCtD
Succinylcholine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000324	0.0029	CcSEcCtD
Succinylcholine—Urticaria—Triamcinolone—multiple sclerosis	0.000321	0.00287	CcSEcCtD
Succinylcholine—Urticaria—Methylprednisolone—multiple sclerosis	0.00032	0.00287	CcSEcCtD
Succinylcholine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000319	0.00286	CcSEcCtD
Succinylcholine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000319	0.00286	CcSEcCtD
Succinylcholine—Shock—Prednisone—multiple sclerosis	0.000314	0.00281	CcSEcCtD
Succinylcholine—Tachycardia—Prednisone—multiple sclerosis	0.000311	0.00279	CcSEcCtD
Succinylcholine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000298	0.00266	CcSEcCtD
Succinylcholine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000297	0.00266	CcSEcCtD
Succinylcholine—Urticaria—Betamethasone—multiple sclerosis	0.000291	0.00261	CcSEcCtD
Succinylcholine—Urticaria—Dexamethasone—multiple sclerosis	0.000291	0.00261	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000291	0.0026	CcSEcCtD
Succinylcholine—Body temperature increased—Betamethasone—multiple sclerosis	0.00029	0.00259	CcSEcCtD
Succinylcholine—Body temperature increased—Dexamethasone—multiple sclerosis	0.00029	0.00259	CcSEcCtD
Succinylcholine—Myalgia—Methotrexate—multiple sclerosis	0.000278	0.00249	CcSEcCtD
Succinylcholine—Rash—Prednisolone—multiple sclerosis	0.000277	0.00248	CcSEcCtD
Succinylcholine—Dermatitis—Prednisolone—multiple sclerosis	0.000277	0.00248	CcSEcCtD
Succinylcholine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000267	0.00239	CcSEcCtD
Succinylcholine—Rash—Triamcinolone—multiple sclerosis	0.000255	0.00228	CcSEcCtD
Succinylcholine—Dermatitis—Triamcinolone—multiple sclerosis	0.000254	0.00228	CcSEcCtD
Succinylcholine—Rash—Methylprednisolone—multiple sclerosis	0.000254	0.00227	CcSEcCtD
Succinylcholine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000254	0.00227	CcSEcCtD
Succinylcholine—Urticaria—Prednisone—multiple sclerosis	0.000253	0.00227	CcSEcCtD
Succinylcholine—Body temperature increased—Prednisone—multiple sclerosis	0.000252	0.00226	CcSEcCtD
Succinylcholine—Hypotension—Methotrexate—multiple sclerosis	0.000249	0.00223	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000243	0.00218	CcSEcCtD
Succinylcholine—Hypersensitivity—Prednisone—multiple sclerosis	0.000235	0.0021	CcSEcCtD
Succinylcholine—Rash—Betamethasone—multiple sclerosis	0.000231	0.00207	CcSEcCtD
Succinylcholine—Rash—Dexamethasone—multiple sclerosis	0.000231	0.00207	CcSEcCtD
Succinylcholine—Dermatitis—Betamethasone—multiple sclerosis	0.000231	0.00207	CcSEcCtD
Succinylcholine—Dermatitis—Dexamethasone—multiple sclerosis	0.000231	0.00207	CcSEcCtD
Succinylcholine—Urticaria—Methotrexate—multiple sclerosis	0.000212	0.0019	CcSEcCtD
Succinylcholine—Body temperature increased—Methotrexate—multiple sclerosis	0.000211	0.00189	CcSEcCtD
Succinylcholine—Rash—Prednisone—multiple sclerosis	0.000201	0.0018	CcSEcCtD
Succinylcholine—Dermatitis—Prednisone—multiple sclerosis	0.000201	0.0018	CcSEcCtD
Succinylcholine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000196	0.00176	CcSEcCtD
Succinylcholine—Rash—Methotrexate—multiple sclerosis	0.000168	0.00151	CcSEcCtD
Succinylcholine—Dermatitis—Methotrexate—multiple sclerosis	0.000168	0.0015	CcSEcCtD
Succinylcholine—CHRM1—Signaling by GPCR—RGS1—multiple sclerosis	1.62e-07	0.00164	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—RGS1—multiple sclerosis	1.61e-07	0.00163	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	1.61e-07	0.00162	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	1.6e-07	0.00162	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CCR1—multiple sclerosis	1.55e-07	0.00156	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	1.55e-07	0.00156	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CXCL13—multiple sclerosis	1.54e-07	0.00156	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CCR1—multiple sclerosis	1.54e-07	0.00156	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—GPR65—multiple sclerosis	1.54e-07	0.00155	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—GPR65—multiple sclerosis	1.53e-07	0.00155	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	1.53e-07	0.00154	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	1.53e-07	0.00154	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	1.52e-07	0.00153	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	1.49e-07	0.00151	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.49e-07	0.00151	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	1.49e-07	0.0015	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LINGO1—multiple sclerosis	1.48e-07	0.0015	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LINGO1—multiple sclerosis	1.48e-07	0.0015	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	1.47e-07	0.00149	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	1.47e-07	0.00148	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—CXCL10—multiple sclerosis	1.47e-07	0.00148	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—CXCL10—multiple sclerosis	1.46e-07	0.00148	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	1.45e-07	0.00146	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	1.45e-07	0.00146	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CYP27B1—multiple sclerosis	1.43e-07	0.00144	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CYP24A1—multiple sclerosis	1.43e-07	0.00144	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—RRM1—multiple sclerosis	1.41e-07	0.00142	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCR1—multiple sclerosis	1.4e-07	0.00142	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CXCL13—multiple sclerosis	1.4e-07	0.00142	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CXCL13—multiple sclerosis	1.4e-07	0.00142	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCR1—multiple sclerosis	1.4e-07	0.00142	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	1.4e-07	0.00142	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	1.39e-07	0.00141	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	1.39e-07	0.0014	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	1.39e-07	0.0014	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GPC5—multiple sclerosis	1.3e-07	0.00132	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TAGAP—multiple sclerosis	1.29e-07	0.0013	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TAGAP—multiple sclerosis	1.28e-07	0.0013	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	1.27e-07	0.00129	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—CCL5—multiple sclerosis	1.26e-07	0.00128	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—CCL5—multiple sclerosis	1.26e-07	0.00127	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	1.24e-07	0.00126	CbGpPWpGaD
Succinylcholine—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.22e-07	0.00124	CbGpPWpGaD
Succinylcholine—CHRM1—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	1.19e-07	0.00121	CbGpPWpGaD
Succinylcholine—CHRM3—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	1.19e-07	0.0012	CbGpPWpGaD
Succinylcholine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	1.18e-07	0.00119	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.17e-07	0.00118	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.16e-07	0.00118	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.15e-07	0.00116	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.14e-07	0.00115	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.14e-07	0.00115	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—CCR5—multiple sclerosis	1.14e-07	0.00115	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—CCR5—multiple sclerosis	1.13e-07	0.00115	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.13e-07	0.00114	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—S1PR1—multiple sclerosis	1.13e-07	0.00114	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	1.12e-07	0.00113	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—S1PR1—multiple sclerosis	1.12e-07	0.00113	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	1.11e-07	0.00112	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GPC5—multiple sclerosis	1.09e-07	0.00111	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GPC5—multiple sclerosis	1.09e-07	0.0011	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.09e-07	0.0011	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.08e-07	0.00109	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—RRM1—multiple sclerosis	1.08e-07	0.00109	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	1.08e-07	0.00109	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	1.06e-07	0.00107	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PTGER4—multiple sclerosis	1.06e-07	0.00107	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	1.05e-07	0.00106	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	1.02e-07	0.00104	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CXCR3—multiple sclerosis	1.02e-07	0.00103	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	1.01e-07	0.00102	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	1e-07	0.00101	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	9.97e-08	0.00101	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	9.96e-08	0.00101	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	9.93e-08	0.001	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	9.88e-08	0.000999	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	9.84e-08	0.000995	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	9.63e-08	0.000974	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	9.6e-08	0.000971	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	9.57e-08	0.000968	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	9.54e-08	0.000965	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	9.51e-08	0.000962	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	9.44e-08	0.000955	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—MAPK1—multiple sclerosis	9.37e-08	0.000948	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.37e-08	0.000948	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	9.3e-08	0.000941	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	9.27e-08	0.000938	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	9.2e-08	0.00093	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	9.18e-08	0.000929	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	9.17e-08	0.000927	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	9.08e-08	0.000918	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	9.07e-08	0.000917	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	9.05e-08	0.000915	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	9.04e-08	0.000915	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	9.02e-08	0.000912	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	8.95e-08	0.000906	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	8.93e-08	0.000904	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	8.91e-08	0.000901	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	8.88e-08	0.000898	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	8.88e-08	0.000898	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	8.85e-08	0.000895	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	8.77e-08	0.000887	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.73e-08	0.000883	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	8.69e-08	0.000879	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	8.66e-08	0.000876	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	8.58e-08	0.000868	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.54e-08	0.000864	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	8.35e-08	0.000845	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	8.32e-08	0.000842	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	8.29e-08	0.000839	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	8.29e-08	0.000839	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	8.28e-08	0.000838	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	8.27e-08	0.000836	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	8.27e-08	0.000836	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	8.25e-08	0.000835	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	8.24e-08	0.000834	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	8.19e-08	0.000828	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	8.19e-08	0.000828	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	8.17e-08	0.000827	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—POMC—multiple sclerosis	8.1e-08	0.000819	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	7.92e-08	0.000801	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	7.52e-08	0.000761	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	7.49e-08	0.000758	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	7.42e-08	0.000751	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	7.22e-08	0.000731	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	7.13e-08	0.000721	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	7.1e-08	0.000719	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	7.04e-08	0.000712	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.84e-08	0.000692	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.82e-08	0.00069	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	6.47e-08	0.000655	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	6.45e-08	0.000653	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	6.42e-08	0.00065	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	6.4e-08	0.000647	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	6.39e-08	0.000646	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	6.34e-08	0.000641	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	6.33e-08	0.00064	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	6.31e-08	0.000638	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	6.25e-08	0.000632	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—BCHE—multiple sclerosis	6.21e-08	0.000628	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	5.91e-08	0.000598	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	5.89e-08	0.000596	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	5.83e-08	0.00059	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	5.83e-08	0.00059	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	5.81e-08	0.000588	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	5.76e-08	0.000582	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	5.75e-08	0.000581	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	5.73e-08	0.000579	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	5.69e-08	0.000576	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	5.67e-08	0.000574	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	5.67e-08	0.000574	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	5.62e-08	0.000568	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PGR—multiple sclerosis	5.6e-08	0.000567	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PGR—multiple sclerosis	5.59e-08	0.000565	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	5.53e-08	0.000559	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	5.49e-08	0.000556	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	5.48e-08	0.000554	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CD28—multiple sclerosis	5.44e-08	0.000551	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CD28—multiple sclerosis	5.43e-08	0.000549	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	5.42e-08	0.000549	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	5.37e-08	0.000544	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	5.35e-08	0.000541	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	5.33e-08	0.000539	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	5.28e-08	0.000534	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	5.02e-08	0.000508	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	5e-08	0.000506	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	4.95e-08	0.000501	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	4.93e-08	0.000499	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	4.92e-08	0.000497	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	4.87e-08	0.000493	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOE—multiple sclerosis	4.86e-08	0.000491	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	4.56e-08	0.000461	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	4.54e-08	0.00046	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	4.5e-08	0.000455	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	4.46e-08	0.000451	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	4.44e-08	0.00045	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	4.44e-08	0.000449	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	4.43e-08	0.000448	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	4.4e-08	0.000445	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	4.38e-08	0.000444	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—POMC—multiple sclerosis	4.17e-08	0.000422	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	4.05e-08	0.00041	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	4.04e-08	0.000408	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	4e-08	0.000404	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	3.88e-08	0.000393	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CD86—multiple sclerosis	3.87e-08	0.000392	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	3.83e-08	0.000388	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	3.82e-08	0.000387	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	3.81e-08	0.000386	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ALB—multiple sclerosis	3.8e-08	0.000385	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	3.77e-08	0.000382	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOE—multiple sclerosis	3.74e-08	0.000378	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	3.71e-08	0.000375	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	3.7e-08	0.000374	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	3.66e-08	0.00037	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	3.54e-08	0.000358	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	3.53e-08	0.000357	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	3.5e-08	0.000354	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	3.44e-08	0.000348	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	3.43e-08	0.000347	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	3.4e-08	0.000344	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	3.39e-08	0.000343	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	3.38e-08	0.000342	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	3.37e-08	0.000341	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	3.36e-08	0.00034	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	3.35e-08	0.000339	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	3.33e-08	0.000336	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—POMC—multiple sclerosis	3.21e-08	0.000325	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	3.13e-08	0.000317	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	3.12e-08	0.000316	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	3.09e-08	0.000313	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ALB—multiple sclerosis	2.93e-08	0.000296	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	2.83e-08	0.000287	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	2.82e-08	0.000286	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	2.8e-08	0.000283	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	2.69e-08	0.000272	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	2.68e-08	0.000271	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	2.66e-08	0.000269	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	2.63e-08	0.000266	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	2.63e-08	0.000266	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	2.6e-08	0.000263	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	2.58e-08	0.000261	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	2.57e-08	0.00026	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	2.54e-08	0.000257	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	2.39e-08	0.000242	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	2.38e-08	0.000241	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	2.36e-08	0.000239	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	1.99e-08	0.000201	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	1.98e-08	0.000201	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	1.98e-08	0.0002	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	1.97e-08	0.0002	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	1.96e-08	0.000199	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	1.95e-08	0.000198	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	1.88e-08	0.000191	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	1.88e-08	0.00019	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	1.86e-08	0.000188	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	1.67e-08	0.000169	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	1.67e-08	0.000169	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	1.65e-08	0.000167	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	1.56e-08	0.000157	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.55e-08	0.000157	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	1.55e-08	0.000157	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	1.55e-08	0.000157	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	1.54e-08	0.000155	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	1.53e-08	0.000155	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.52e-08	0.000154	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	1.52e-08	0.000154	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	1.5e-08	0.000152	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	1.17e-08	0.000118	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	1.17e-08	0.000118	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	1.15e-08	0.000117	CbGpPWpGaD
